IDYA (IDEAYA Biosciences) Accumulated Depreciation: $-15.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IDYA IDEAYA Biosciences Inc IDYA
48 GF Score
Price $36.30
GF Value $240.68
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is IDEAYA Biosciences Accumulated Depreciation?

IDEAYA Biosciences IDYA -1.08% 48 Accumulated Depreciation is $-15.6 Mil as of Jun. 2026. GuruFocus rates IDYA with a GF Score™ of 48/100 and a GF Value™ of $240.68 (Possible Value Trap). The stock has 6 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

IDEAYA Biosciences's quarterly accumulated depreciation increased from Dec. 2025 ($-14.3 Mil) to Mar. 2026 ($-14.9 Mil) and increased from Mar. 2026 ($-14.9 Mil) to Jun. 2026 ($-15.6 Mil).

IDEAYA Biosciences's annual accumulated depreciation increased from Dec. 2023 ($-9.6 Mil) to Dec. 2024 ($-11.7 Mil) and increased from Dec. 2024 ($-11.7 Mil) to Dec. 2025 ($-14.3 Mil).

IDEAYA Biosciences Accumulated Depreciation Related Terms

IDEAYA Biosciences Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for IDEAYA Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEAYA Biosciences Accumulated Depreciation Chart

IDEAYA Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only -5.60 -7.55 -9.61 -11.71 -14.26

IDEAYA Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.01 -13.69 -14.26 -14.95 -15.63
IDYA
48GF Score
IDEAYA Biosciences Inc IDYA
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEAYA Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-15.6 Mil mean?
IDEAYA Biosciences (IDYA) has a Accumulated Depreciation of $-15.6 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on IDEAYA Biosciences and its competitors.
Is IDEAYA Biosciences' Accumulated Depreciation too high?
IDEAYA Biosciences' current Accumulated Depreciation is $-15.6 Mil. Overall, IDEAYA Biosciences has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IDEAYA Biosciences' Accumulated Depreciation compare to ARQT and NAMS?
IDEAYA Biosciences' Accumulated Depreciation of $-15.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on IDEAYA Biosciences and its competitors. IDEAYA Biosciences's current Accumulated Depreciation is $-15.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEAYA Biosciences stock overvalued right now?
Based on GuruFocus' analysis, IDEAYA Biosciences (IDYA) is currently considered Possible Value Trap. The stock's GF Value™ is $240.68, compared to a current price of $36.30 — trading 84.9% below its estimated fair value. The current Accumulated Depreciation is $-15.6 Mil. IDEAYA Biosciences' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For IDEAYA Biosciences (IDYA), the current Accumulated Depreciation is $-15.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEAYA Biosciences (IDYA) Overvalued in 2026?

Based on GuruFocus' analysis, IDEAYA Biosciences stock appears to be undervalued. The current stock price of $36.30 is trading 84.9% below its estimated GF Value™ of $240.68. GuruFocus considers IDEAYA Biosciences to be Possible Value Trap.

Key valuation signals for IDYA:

  • Accumulated Depreciation: $-15.6 Mil
  • GF Value™: $240.68 vs. price of $36.30 (84.9% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the IDYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEAYA Biosciences Business Description

Other Exchanges 30J:Germany
Address 5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
48GF Score

Get the complete analysis for IDYA

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.30
Price
$240.68
GF Value